Elicio Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
Elicio Therapeutics Total Assets Growth & History (ELTX)
Elicio Therapeutics's total assets was $25.9M for fiscal 2025.
View full Elicio Therapeutics company overviewElicio Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $25.9M | −$2.3M | −8.22% |
| 2024 | 2024-12-31 | $28.2M | $1.0M | +3.80% |
| 2023 | 2023-12-31 | $27.1M | $4.5M | +19.78% |
| 2022 | 2022-12-31 | $22.7M | −$73.8M | −76.52% |
| 2021 | 2021-12-31 | $96.5M | $49.2M | +103.84% |
| 2020 | 2020-12-31 | $47.3M | — | — |
Elicio Therapeutics quarterly total assets
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $31.3M | $1.8M | +6.10% |
| Q1 2026 | 2026-03-31 | $22.7M | −$5.5M | −19.38% |
| Q4 2025 | 2025-12-31 | $25.9M | −$2.3M | −8.22% |
| Q3 2025 | 2025-09-30 | $28.3M | −$10.1M | −26.32% |
| Q2 2025 | 2025-06-30 | $29.5M | $13.8M | +87.48% |
| Q1 2025 | 2025-03-31 | $28.1M | $3.7M | +14.97% |
| Q4 2024 | 2024-12-31 | $28.2M | $1.0M | +3.80% |
| Q3 2024 | 2024-09-30 | $38.4M | $7.4M | +23.88% |
| Q2 2024 | 2024-06-30 | $15.8M | −$21.9M | −58.13% |
| Q1 2024 | 2024-03-31 | $24.5M | −$17.3M | −41.39% |
| Q4 2023 | 2023-12-31 | $27.1M | $4.5M | +19.78% |
| Q3 2023 | 2023-09-30 | $31.0M | −$30.3M | −49.46% |
| Q2 2023 | 2023-06-30 | $37.6M | −$33.2M | −46.88% |
| Q1 2023 | 2023-03-31 | $41.8M | −$39.5M | −48.60% |
| Q4 2022 | 2022-12-31 | $22.7M | −$73.8M | −76.52% |
| Q3 2022 | 2022-09-30 | $61.3M | −$48.6M | −44.23% |
| Q2 2022 | 2022-06-30 | $70.8M | −$54.5M | −43.51% |
| Q1 2022 | 2022-03-31 | $81.3M | −$57.9M | −41.63% |
| Q4 2021 | 2021-12-31 | $96.5M | $49.2M | +103.84% |
| Q3 2021 | 2021-09-30 | $109.9M | — | — |
| Q2 2021 | 2021-06-30 | $125.4M | — | — |
| Q1 2021 | 2021-03-31 | $139.2M | — | — |
| Q4 2020 | 2020-12-31 | $47.3M | — | — |
Elicio Therapeutics total assets trends
Over the last five fiscal years, Elicio Therapeutics's total assets decreased from $47.3M to $25.9M, a change of −$21.5M. The latest reported quarter, Q2 2026, shows $31.3M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Elicio Therapeutics source filings ↗